Literature DB >> 20484015

Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2.

Bingsen Zhou1, Leila Su, Yate-Ching Yuan, Frank Un, Norby Wang, Madhukar Patel, Bixin Xi, Shuya Hu, Yun Yen.   

Abstract

Ribonucleotide reductase (RNR) is an enzyme for the de novo conversion of ribonucleotides to deoxyribonucleotides. The two human RNR small subunits hRRM2 and hp53R2 share 83% sequence homology but show distinct expression patterns and function. Structural analyses of the oxidized form of hRRM2 and hp53R2 indicate that both proteins contain a conserved Gln127-hp53R2/Gln165-hRRM2 close to the dinuclear iron center and the essential tyrosine residue Tyr124-hp53R2/Tyr162-hRRM2 forms hydrogen bonds with the tyrosine and iron ligands, implying a critical role for the glutamine residue in assembling the dityrosyl-diiron radical cofactor. The present work also showed that Tyr221 in hRRM2, which is replaced by Phe183 in hp53R2, forms a hydrogen bond with Tyr162 to extend the hydrogen bond network from Gln165-hRRM2. Mutagenesis and spectroscopic experiments suggested that the tyrosine-to-phenylalanine switch at Phe183-hp53R2/Tyr221-hRRM2 could lead to differences in radical generation or enzymatic activity for hp53R2 and hRRM2. This study correlates the distinct catalytic mechanisms of the small subunits hp53R2 and hRRM2 with a hydrogen-bonding network and provides novel directions for designing and developing subunit-specific therapeutic agents for human RNR enzymes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484015      PMCID: PMC3050530          DOI: 10.1158/1535-7163.MCT-10-0023

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  36 in total

Review 1.  Structure and function of the radical enzyme ribonucleotide reductase.

Authors:  H Eklund; U Uhlin; M Färnegårdh; D T Logan; P Nordlund
Journal:  Prog Biophys Mol Biol       Date:  2001-11       Impact factor: 3.667

2.  In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase.

Authors:  Jimin Shao; Bingsen Zhou; Lijun Zhu; Weihua Qiu; Yate-Ching Yuan; Bixin Xi; Yun Yen
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

Review 3.  Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents.

Authors:  Nuno M F S A Cerqueira; Pedro A Fernandes; Maria J Ramos
Journal:  Recent Pat Anticancer Drug Discov       Date:  2007-01       Impact factor: 4.169

Review 4.  Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer?

Authors:  JoAnne Stubbe; Daniel G Nocera; Cyril S Yee; Michelle C Y Chang
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

5.  High-frequency (140-GHz) time domain EPR and ENDOR spectroscopy: the tyrosyl radical-diiron cofactor in ribonucleotide reductase from yeast.

Authors:  G Bar; M Bennati; H H Nguyen; J Ge; J A Stubbe; R G Griffin
Journal:  J Am Chem Soc       Date:  2001-04-18       Impact factor: 15.419

6.  Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.

Authors:  O Guittet; P Håkansson; N Voevodskaya; S Fridd; A Gräslund; H Arakawa; Y Nakamura; L Thelander
Journal:  J Biol Chem       Date:  2001-08-21       Impact factor: 5.157

7.  Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools.

Authors:  Takashi Kimura; Satoshi Takeda; Yoji Sagiya; Mitsukazu Gotoh; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

Review 8.  Structure, function, and mechanism of ribonucleotide reductases.

Authors:  Matthias Kolberg; Kari R Strand; Pål Graff; K Kristoffer Andersson
Journal:  Biochim Biophys Acta       Date:  2004-06-01

9.  In vivo assay for low-activity mutant forms of Escherichia coli ribonucleotide reductase.

Authors:  Monica Ekberg; Pernilla Birgander; Britt-Marie Sjöberg
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

10.  2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase .

Authors:  Peter Smith; Bingsen Zhou; Nam Ho; Yate-Ching Yuan; Leila Su; Shiou-Chuan Tsai; Yun Yen
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

View more
  5 in total

1.  Proton Coupled Electron Transfer and Redox Active Tyrosines: Structure and Function of the Tyrosyl Radicals in Ribonucleotide Reductase and Photosystem II.

Authors:  Bridgette A Barry; Jun Chen; James Keough; David Jenson; Adam Offenbacher; Cynthia Pagba
Journal:  J Phys Chem Lett       Date:  2012-02-08       Impact factor: 6.475

2.  A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Authors:  Bingsen Zhou; Leila Su; Shuya Hu; Weidong Hu; M L Richard Yip; Jun Wu; Shikha Gaur; D Lynne Smith; Yate-Ching Yuan; Timothy W Synold; David Horne; Yun Yen
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

3.  Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.

Authors:  Iosifina P Foskolou; Christian Jorgensen; Katarzyna B Leszczynska; Monica M Olcina; Hanna Tarhonskaya; Bauke Haisma; Vincenzo D'Angiolella; William K Myers; Carmen Domene; Emily Flashman; Ester M Hammond
Journal:  Mol Cell       Date:  2017-04-13       Impact factor: 17.970

4.  A novel clade of unique eukaryotic ribonucleotide reductase R2 subunits is exclusive to apicomplexan parasites.

Authors:  James B Munro; Christopher G Jacob; Joana C Silva
Journal:  J Mol Evol       Date:  2013-09-18       Impact factor: 2.395

5.  PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.

Authors:  Mei-Ling Kuo; Mabel Bin-Er Lee; Michelle Tang; Willem den Besten; Shuya Hu; Michael J Sweredoski; Sonja Hess; Chih-Ming Chou; Chun A Changou; Mingming Su; Wei Jia; Leila Su; Yun Yen
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.